This topic contains a solution. Click here to go to the answer

Author Question: You are responding to a report of an explosion at the post office. A unique safety consideration in ... (Read 241 times)

shenderson6

  • Hero Member
  • *****
  • Posts: 573
You are responding to a report of an explosion at the post office. A unique safety consideration in this situation is:
 
  A) hazardous materials.
  B) the possibility of a second explosive device.
  C) an unstable building structure.
  D) broken glass and sharp metal.

Question 2

As pressure inside the skull continues to increase, it pushes the brain tissue through the foramen magnum. This is known as:
 
  A) herniation.
  B) Cushing reflex.
  C) posturing.
  D) concussion.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bfulkerson77

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

A





 

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Patients who have been on total parenteral nutrition for more than a few days may need to have foods gradually reintroduced to give the digestive tract time to start working again.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library